EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year

The success rate for small biotechs applying for regulatory approval from the EMA has risen by over 100% since 2016, which analysts partly attribute to increased access to sophisticated technology and funding.

According to a recent announcement from the EMA, the regulator greenlit a whopping 89% of applications for marketing authorization for new medicines from a micro-, small-, or medium-sized enterprise (SME) applicant last year. This figure dwarfs the 40% success rate for SMEs in 2016.

Read the source article at Labiotech.eu
2021-07-14 14:31:44